Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1057-1064

  Arai, Takao ^a,c   Benny, Ofra ^b   Joki, Tatsuhiro ^c   Menon, Lata G ^a   Machluf, Marcelle ^b   Abe, Toshiaki ^c   Carroll, Rona S ^a   Black, Peter M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxorubicin; Drug delivery system; Liposome; Malignant glioma; Polymeric microsphere; Thermoreversible gelation polymer

Indexed keywords

DOXORUBICIN; LIPOSOME; MICROSPHERE; POLYMER; THERMOREVERSIBLE GELATION POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; FETUS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE TUMOR; TREATMENT OUTCOME;

ACRYLAMIDES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLIOBLASTOMA; HOT TEMPERATURE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSOMES; MALE; METHACRYLATES; MICE; MICE, NUDE; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYMERS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953785349     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Behin A, Hoang-Xuan K, Carpentier AF and Delattre JY: Primary brain tumours in adults. Lancet 361: 323-331, 2003.
2. Groothuis DR: The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncol 2: 45-59, 2000.
3. Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, Abe T, Carroll RS and Black PM: Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 79: 35-39, 2001.
4. Manome Y, Kobayashi T, Mori M, Suzuki R, Funamizu N, Akiyama N, Inoue S, Tabata Y and Watanabe M: Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet. Anticancer Res 26: 3317-3326, 2006.
5. Menei P, Jadaud E, Faisant N, Boisdron-Celle M, Michalak S, Fournier D, Delhaye M and Benoit JP: Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer 100: 405-410, 2004.
6. Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW and Bankiewicz KS: Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neurooncol 8: 205-214, 2006.
7. Ugur HC, Ramakrishna N, Bello L, Menon LG, Kim SK, Black PM and Carroll RS: Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol 83: 267-275, 2007.
8. Walter KA, Tamargo RJ, Olivi A, Burger PC and Brem H: Intratumoral chemotherapy. Neurosurgery 37: 1128-1145, 1995.
9. Yoshioka H, Mikami M, Mori Y and Tsuchida E: A synthetic hydrogel with thermoreversible gelation, I: Preparation and rheological properties. J Macromol Sci A31: 113-120, 1994.
10. Hishikawa K, Miura S, Marumo T, Yoshioka H, Mori Y, Takato T and Fujita T: Gene expression profile of human mesenchymal stem cells during osteogenesis in three-dimensional thermoreversible gelation polymer. Biochem Biophys Res Commun 317: 1103-1107, 2004.
11. Medina RJ, Kataoka K, Takaishi M, Miyazaki M and Huh NH: Isolation of epithelial stem cells from dermis by a three-dimensional culture system. J Cell Biochem 98: 174-184, 2006.
12. Murakami K, Ishii K, Ishihara Y, Yoshizaki S, Tanaka K, Gotoh Y, Aizaki H, Kohara M, Yoshioka H, Mori Y, Manabe N, Shoji I, Sata T, Bartenschlager R, Matsuura Y, Miyamura T and Suzuki T: Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype lb. Virology 351: 381-392, 2006.
13. Nagaya M, Kubota S, Suzuki N, Tadokoro M and Akashi K: Evaluation of thermoreversible gelation polymer for regeneration of focal liver injury. Eur Surg Res 36: 95-103, 2004.
14. Nagaya M, Kubota S, Suzuki N, Akashi K and Mitaka T: Thermoreversible gelation polymer induces the emergence of hepatic stem cells in the partially injured rat liver. Hepatology 43: 1053-1062, 2006.
15. Yasuda A, Kojima K, Tinsley KW, Yoshioka H, Mori Y and Vacanti CA: In vitro culture of chondrocytes in a novel thermoreversible gelation polymer scaffold containing growth factors. Tissue Eng 12: 1237-1245, 2006.
16. Yoshioka H, Mori Y and Shimizu M: Separation and recovery of DNA fragments by electrophoresis through a thermoreversible hydrogel composed of poly(ethylene oxide) and poly(propylene oxide). Anal Biochem 323: 218-223, 2003.
17. Takao H, Murayama Y, Yuki I, Ishibashi T, Ebara M, Irie K, Yoshioka H, Mori Y, Vinuela F and Abe T: Endovascular treatment of experimental aneurysms using a combination of thermoreversible gelation polymer and protection devices: feasibility study. Neurosurgery 65: 601-609, 2009.
18. Arai T, Joki T, Akiyama M, Agawa M, Mori Y, Yoshioka H and Abe T: Novel drug delivery system using thermoreversible gelation polymer for malignant glioma. J Neurooncol 77: 9-15, 2006.
19. Benny O, Duvshani-Eshet M, Cargioli T, Bello L, Bikfalvi A, Carroll RS and Machluf M: Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. Clin Cancer Res 11: 768-776, 2005.
20. Badalament RA and Farah RN: Treatment of superficial bladder cancer with intravesical chemotherapy. Semin Surg Oncol 13: 335-341, 1997. (Pubitemid 27332856)
21. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997.
22. Stupp R, Mason WP, van den Bent MJ, Weiler M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10): 987-996, 2005.
23. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S and Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-Brain Tumor Treatment Group. Lancet 345: 1008-1012, 1995.
24. Menei P, Capelle L, Guyotat J, Fuentes S, Assaker R, Bataille B, Francois P, Dorwling-Carter D, Paquis P, Bauchet L, Parker F, Sabatier J, Faisant N and Benoit JP: Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 56: 242-248, 2005.
25. Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS and Park JW: Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors pharmacology and efficacy. Cancer Res 66: 2801-2806, 2006.
26. Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS and Bankiewicz KS: Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64: 2572-2579, 2004.
27. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G and Kuurne T: Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41: 44-48, 1997.
28. Lesniak MS, Upadhyay U, Goodwin R, Tyler B and Brem H: Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res 25: 3825-3832, 2005.
29. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warlike PC, Whittle IR, Jaaskelainen J and Ram Z: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 5: 79-88, 2003.
30. Voulgaris S, Partheni M, Karamouzis M, Dimopoulus P, Papadakis N and Kalofonos HP: Intratumoral doxorubicin in patients with malignant brain gliomas. Am J Clin Oncol 25: 60-64, 2002.
31. Yamashita Y, Krauze MT, Kawaguchi T, Noble CO, Drummond DC, Park JW and Bankiewicz KS: Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro-oncol 9: 20-28, 2007.
32. Alonso MJ, Gupta RK, Min C, Siber GR and Langer R: Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12: 299-306, 1994.
33. Mullerad J, Cohen S, Voronov E and Apte RN: Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres. Cytokine 12: 1683-1690, 2000.
34. Seagal J, Edry E, Keren Z, Leider N, Benny O, Machluf M and Melamed D: A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway. J Exp Med 198: 1609-1619, 2003.
35. Allen TM and Martin FJ: Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 31: 5-15, 2004.
36. Allen TM, Newman MS, Woodle MC, Mayhew E and Uster PS: Pharmacokinetics and anti tumor activity of vincristine encapsulated in sterically stabilized liposomes. Int J Cancer 62: 199-204, 1995.
37. Drummond DC, Meyer O, Hong K, Kirpotin DB and Papahadjopoulos D: Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51: 691-743, 1999.
38. Gabizon A, Shmeeda H and Barenholz Y: Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42: 419-436, 2003.
39. Harrington KJ: Liposomal cancer chemotherapy: current clinical applications and future prospects. Expert Opin Investig Drugs 10: 1045-1061, 2001.
40. Krauze MT, Noble CO, Kawaguchi T, Drummond D, Kirpotin DB, Yamashita Y, Kullberg E, Forsayeth J, Park JW and Bankiewicz KS; Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro-oncol 9: 393-403, 2007.